Anita K. Gandhi - Concepedia

Author

Anita K. Gandhi

Also Known As

A K Gandhi, A. Gandhi, A. K Gandhi, A. K. Gandhi, A. Krithivas Gandhi, ANITA GANDHI, Anita Gandhi, Anita K Gandhi, Anita K. Gandhi, Anita Krithivas Gandhi

225

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (Switzerland)Bristol-Myers Squibb (United States)King's College London Institut Gustave Roussy Mayo Clinic in Arizona

About

Anita K. Gandhi is an author at Bristol-Myers Squibb (Switzerland) specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.2K
2	Cell Biology	3	3	1.1K
3	Education	1	1	136
4	Health Sciences	1	1	16
5	Social Sciences	1	1	136

Anita K. Gandhi

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS Jan Krönke, Emma C. Fink, Paul W. Hollenbach, Nature MedicineCell DeathPharmacologyCell BiologyCell Signaling	2015	816
Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide Antonia Lopez‐Girona, Derek Mendy, Takumi Ito, Leukemia	2012	783
Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate <scp>T</scp> cells by inducing degradation of <scp>T</scp> cell repressors <scp>I</scp> karos and <scp>A</scp> iolos via modulation of the <scp>E</scp> 3 ubiquitin ligase complex <scp>CRL</scp> 4 <scp> <sup>CRBN</sup> </scp> Anita K. Gandhi, Jian Kang, Courtney G. Havens, British Journal of Haematology	2013	611
Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4 Chad C. Bjorklund, Ling Lu, Jian Kang, Blood Cancer Journal	2015	211
CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL Patrick R. Hagner, Hon‐Wah Man, Celia Fontanillo, Blood	2015	197
Enhancement of Cytokine Production and AP-1 Transcriptional Activity in T Cells by Thalidomide-Related Immunomodulatory Drugs Peter Schäfer, Anita K. Gandhi, Michelle A. Loveland, Journal of Pharmacology and Experimental Therapeutics	2003	179
Pomalidomide and Lenalidomide Induce p21WAF-1 Expression in Both Lymphoma and Multiple Myeloma through a LSD1-Mediated Epigenetic Mechanism Laure Escoubet‐Lozach, I-Lin Lin, Kristen Jensen-Pergakes, Cancer Research	2009	170
Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function Anita K. Gandhi, Jingfen Kang, Lori Capone, Current Cancer Drug Targets ImmunologyImmune RegulationImmunotherapeuticsImmune SystemImmunotherapy	2010	167
Asian Body Image Satisfaction: Ethnic and Gender Differences across Chinese, Indo-Asian, and European-Descent Students Margaret Kennedy, Laura Templeton, Anita K. Gandhi, Eating Disorders EthnicityBody SatisfactionEducationBody Image SatisfactionSocial Sciences	2004	136
Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity Anita K. Gandhi, Derek Mendy, Michelle F. Waldman, British Journal of Haematology	2013	102

Page 1